As in human tRCC, ASPSCR1-TFE3–expressing cells had reduced levels of cytokeratin 18 (CK18), a signature epithelial marker (Figure 2D). This evidence concerns the gene ASPSCR1 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.